Anika CEO retires after two decades; president assumes corner office | Personnel Moves – March 13, 2018

Anika Therapeutics (NSDQ:ANIK) announced this month that CEO Charles Sherwood plans to retire after working for Anika for nearly twenty years. Joseph Darling, who has been Anika’s president since July 2017, will take his place in the corner office.

Darling has previously served in executive leadership roles across an array of medtech companies like Abbott (NYSE:ABT), Baxter (NYSE:BAX) and Smith & Nephew (NYSE:SNN).

“First, I would like to thank Chuck Sherwood for his close to two decades of commitment to Anika and for establishing Anika as a global innovator in joint health and tissue repair,” chairman Joseph Bower said in prepared remarks. “Chuck Sherwood built Anika as we know it. As CEO for 15 years, he has delivered outstanding product innovation and development and operational, commercial, and financial achievements.”

Get the full story at our sister site, Drug Delivery Business News.

The post Anika CEO retires after two decades; president assumes corner office | Personnel Moves – March 13, 2018 appeared first on MassDevice.

OncoSec Medical names new CEO | Personnel Moves – Nov. 9, 2017

Share

OncoSec MedicalOncoSec Medical (NSDQ:ONCS)  announced earlier this week that the company’s co-founder, Punit Dhillon, would step down as CEO and continue to serve as president while Daniel O’Connor takes over the corner office.

O’Connor joined OncoSec’s board of directors in September this year.

“We are pleased to welcome Dan to OncoSec at this important time, and believe he is uniquely qualified to lead the company through the successful completion of its phase IIb registration directed trial, Pisces/Keynote-695 in patients with unresectable metastatic melanoma who have progressed or are progressing on an anti-PD-1 therapy,” chairman Avtar Dhillon said in prepared remarks. “Dan is a proven leader with a strong track record of success and brings exceptional strategic and operational expertise in building thriving, successful biopharma companies.”

Get the full story at our sister site, Drug Delivery Business News.